Tirzepatide usually costs more than semaglutide through telehealth, both as a brand and in compounded form. To compare fairly, line up the same thing across providers: the dose you will actually be on, the weeks each shipment covers, and every fee outside the medication price.
Open almost any GLP-1 telehealth price list and you will see the same pattern: semaglutide sits in one price band, tirzepatide in a higher one. This post explains where that gap comes from and how to compare the two without mixing up brand and compounded prices. We use prices from manufacturer and provider pages we opened on October 29, 2026. Prices move often, so confirm every figure at checkout.
Two different molecules
Semaglutide acts on one hormone receptor, GLP-1. It is the active ingredient in Wegovy, which Novo Nordisk sells as a weekly injection pen and as a daily tablet.
Tirzepatide acts on two: according to the Zepbound prescribing information (revised August 2026), it activates both the GIP and GLP-1 receptors. Eli Lilly sells it for weight management as Zepbound, in single-dose vials, single-dose pens and a multi-dose KwikPen.
The best-known head-to-head data is the SURMOUNT-5 trial, published in the New England Journal of Medicine in 2025. In 751 adults with obesity and without diabetes, average weight change at 72 weeks was −20.2% on tirzepatide versus −13.7% on semaglutide, with each group on its maximum tolerated dose. That is an average across a trial population. It does not predict what one person will experience, and the drugs differ in side effects and suitability. Which one fits you is a clinician's decision, not a price-table decision.
Brand-name vs. compounded
Telehealth providers sell two very different kinds of product, and their prices are not comparable line for line.
Brand-name
Wegovy and Zepbound, made by the manufacturer and dispensed by a pharmacy. Fixed doses, labeled devices, reviewed by the FDA.
Compounded
Prepared by a compounding pharmacy for an individual prescription. The FDA does not review these for safety, effectiveness or quality before sale.
The FDA declared the semaglutide shortage resolved on February 21, 2025, after an earlier order on tirzepatide in December 2024. Compounded versions are still widely sold through telehealth, typically from 503A pharmacies. The FDA has also received adverse event reports linked to dosing errors with compounded semaglutide, including people measuring doses wrong from vials. If you go compounded, ask exactly how your dose is measured. Our brand vs. compounded guide covers the trade-offs in depth.
Brand prices: manufacturer direct-pay programs
Both manufacturers sell to self-pay patients directly. A telehealth clinician can write the prescription, and you buy through the manufacturer's program or a pharmacy.
| Product | Dose | Listed self-pay price |
|---|---|---|
| Wegovy pen (NovoCare) | 0.25 mg through 2.4 mg | $349 |
| Wegovy pen (NovoCare) | 7.2 mg | $399 |
| Wegovy pen, new-patient offer | 0.25 mg and 0.5 mg, first 2 fills, through Dec 31, 2026 | $199 |
| Wegovy pill (NovoCare) | 1.5 mg / 4 mg / 9 mg and 25 mg | $149 / $199 / $299 |
| Zepbound vial or KwikPen (LillyDirect) | 2.5 mg | $299 |
| Zepbound vial or KwikPen (LillyDirect) | 5 mg | $399 |
| Zepbound vial or KwikPen (LillyDirect) | 7.5 mg | $449–$499 |
| Zepbound vial or KwikPen (LillyDirect) | 10 mg, 12.5 mg, 15 mg | $449–$699 |
The Zepbound ranges come from a refill-timing condition. Lilly's terms say the $449 price for 7.5 mg and up applies only if you refill within 45 days of your previous delivery. Refill later and the page lists $499 (7.5 mg) or $699 (10 mg and higher). Lilly defines a month as 28 days. Needles and syringes are bought separately for vials and the KwikPen.
Brand prices quoted inside a telehealth program can be very different. BiltRx's pages (checked October 29, 2026) list Zepbound at $1,499 per month and Wegovy at $1,849. GobyMeds lists Zepbound at $1,399 and Wegovy at $1,695. Before paying a program's brand price, check the manufacturer's self-pay price for the same dose.
Why tirzepatide usually costs more
We can describe the pattern; we cannot see inside anyone's pricing model. What the public price lists show:
- The brand list prices differ. Lilly's Zepbound self-pay prices at maintenance doses ($449–$699) sit above NovoCare's main Wegovy pen price ($349) as of October 29, 2026.
- Tirzepatide doses are larger in milligrams. Zepbound's labeled doses run from 2.5 mg to 15 mg weekly. Wegovy injection doses run from 0.25 mg to 2.4 mg, with 7.2 mg as an option. Compounded products are priced by the pharmacy, and higher doses mean more active ingredient per vial.
- Providers price them separately. Every partner page we checked that prices the two molecules separately lists tirzepatide higher. BiltRx lists $81 per month for compounded semaglutide and $129 for tirzepatide. HealthRX's monthly subscriptions renew at $165 and $214.
Dose-tier pricing changes the comparison
A single "from" price usually reflects the starting dose. Several providers tier prices by dose, and you will move up those tiers during the first months.
GobyMeds' pricing page (October 29, 2026) is explicit. Its 3-month compounded semaglutide bundles run $299, $399 or $499 depending on dose range. Its tirzepatide 3-month bundles run $399, $499 or $599, and the page says tirzepatide pricing is based on the highest weekly dose included in your 12-week plan. Gala GLP-1's site, by contrast, says a higher dose is available at no additional cost.
Flat versus tiered pricing can matter more than the starting price. Our medication formats guide explains how vials, pens and tablets affect what you buy. Either way, ask each provider for its price at every dose step before you enroll.
Side-by-side: listed compounded prices
These are the partner prices we could verify on provider pages on October 29, 2026. "Not listed" means the page showed no price for that item; it does not mean free.
| Provider | Semaglutide | Tirzepatide | What else to ask |
|---|---|---|---|
| BiltRx | $81/month | $129/month | Consultation and shipping apply separately; amounts not listed |
| GobyMeds | $299 3-month starter; single month $169+ | $399 3-month starter; single month $299+ | 3-month bundles tiered by dose |
| HealthRX | $99 first month, then $165/month; $374 per 12 weeks | $99 first month, then $214/month; $602 per 12 weeks | Injection supplies not confirmed as standard |
| Ivim Health | $65/month on a 12-month term | $117/month, shown with its 12-month option | Membership listed at $75/month, required for medication |
To compare these fairly, convert each one to the same unit, such as the total for 12 weeks at your expected dose including every required fee. Our true-cost calculator does that, and our cheapest-providers guide and no-membership-fee guide narrow the list.
Five questions that make prices comparable
- Brand or compounded?Never compare a compounded price against a brand price as if they were the same product.
- Which dose does this price cover?Ask for the price at the dose you will likely be on by month four, not just the starting dose.
- How many weeks per shipment?Four weeks and one calendar month are not the same. See why four weeks is not one calendar month.
- What is billed separately?Membership, consultation, shipping, labs and syringes can all sit outside the headline.
- What if I switch molecules?Ask whether switching from semaglutide to tirzepatide, or the other way, restarts intro pricing or bundle terms.
Partners to check
Partners to check, listed alphabetically and not ranked. Prices change; confirm the current quote and terms on each provider's site. You can also browse the full provider directory.
BiltRx
Separate compounded semaglutide and tirzepatide pages with monthly prices. Ask what the consult and shipping fees add.
Paid partner linksGobyMeds
Publishes dose-tiered bundles for both molecules, plus brand options. Read the tier your dose falls in.
Paid partner linkHealthRX
Separate pages for each molecule, with monthly and multi-month plans. Compare renewal prices, not the intro month.
Details: semaglutide listing · tirzepatide listing
Paid partner linksIvim Health
Low listed per-month medication prices on longer terms, plus a required monthly membership.
Paid partner linkFrequently asked questions
Why is tirzepatide more expensive than semaglutide through telehealth?
On the price lists we checked, tirzepatide is priced higher for both brand and compounded versions. The brand self-pay price for Zepbound at maintenance doses is above Wegovy's main pen price, and tirzepatide doses are larger in milligrams, which affects compounded pricing.
Is compounded tirzepatide the same as Zepbound?
No. Zepbound is FDA-approved and made by Eli Lilly. Compounded tirzepatide is prepared by a compounding pharmacy and is not FDA-approved, which means the FDA has not reviewed it for safety, effectiveness or quality.
Can a telehealth clinician prescribe Wegovy or Zepbound for manufacturer self-pay pricing?
Manufacturer programs such as NovoCare and LillyDirect fill prescriptions from licensed prescribers, and both list self-pay prices. Check each program's terms for eligibility and how prescriptions are sent.
Does the price go up when my dose increases?
It depends on the provider. Some tier by dose; GobyMeds prices tirzepatide bundles by the highest weekly dose in the plan. Others, such as Gala GLP-1, say higher doses cost no more. Lilly's Zepbound self-pay price also changes by dose.
Which is better for weight loss, semaglutide or tirzepatide?
In the SURMOUNT-5 trial, average weight loss at 72 weeks was greater with tirzepatide than with semaglutide. Averages don't predict individual results, and side effects and medical history matter. A licensed clinician should decide which, if either, is appropriate.
Sources
We opened each source below while preparing this article (checked October 29, 2026). Listing a source does not mean it endorses this site.
- Eli Lilly: Zepbound prescribing information (revised 08/2026) — mechanism, doses
- Novo Nordisk: Wegovy prescribing information (revised 06/2026) — doses for injection and tablet
- ACC journal scan: SURMOUNT-5 (Aronne et al., N Engl J Med 2025;393:26-36) — head-to-head trial results
- NovoCare: Price your Wegovy — self-pay prices
- LillyDirect: Zepbound — self-pay prices by dose
- Lilly: Zepbound self-pay terms and conditions — 45-day refill condition, 28-day month
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss — compounded drugs, dosing errors
- Drug Topics: FDA declares shortage of Ozempic, Wegovy resolved (Feb 21, 2025) — shortage resolution dates
- BiltRx: Compounded semaglutide — listed prices
- BiltRx: Compounded tirzepatide — listed prices
- GobyMeds: Pricing — dose-tiered bundles, brand prices
- HealthRX: Semaglutide — plan prices
- HealthRX: Tirzepatide — plan prices
- Ivim Health: Home page — listed 12-month medication prices
- Ivim Health: Membership — membership price and terms
- Gala GLP-1 — higher-dose pricing statement